Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3809)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2022 (publication date) through Nov 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tanaka T, Sakai A, Tsujimae M, Yamada Y, Kobayashi T, Masuda A, Kodama Y. Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report. World J Gastroenterol 2022; 28(28): 3732-3738 [PMID: 36161046 DOI: 10.3748/wjg.v28.i28.3732] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3732.htm |
| Number | Citing Articles |
| 1 |
Jose M. Pinazo-Bandera, Juan Pedro Toro-Ortiz, Raúl J. Andrade, Miren García-Cortés. Drug-induced cholestasis: causative agents and challenges in diagnosis and management. Exploration of Digestive Diseases 2023; 2(5): 202 doi: 10.37349/edd.2023.00027
|
| 2 |
Joshua Newington, Daniel Patterson, Pilar Sanchez. Delayed onset autoimmune cholangitis in a patient treated with pembrolizumab. BJR|Case Reports 2024; 10(6) doi: 10.1093/bjrcr/uaae040
|
| 3 |
Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi. Late‐onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer. Thoracic Cancer 2023; 14(1): 81 doi: 10.1111/1759-7714.14736
|
| 4 |
Weilun Fang, Wei Sun, Weijin Fang, Jian Zhang, Chunjiang Wang. Clinical features, treatment, and outcome of pembrolizumab induced cholangitis. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(10): 7905 doi: 10.1007/s00210-024-03135-2
|
| 5 |
Einar S. Bjornsson, Harshad C. Devarbhavi. Drug-induced cholestatic liver diseases. Hepatology 2024; doi: 10.1097/HEP.0000000000001052
|
| 6 |
Zheqing Liu, Xiaojing Du, Meiling Deng, Yuanyuan Chen, Shaoxiong Wu. Successful replacement for recurrent nasopharyngeal carcinoma with cholecystitis induced by PD-1 antibody: a case report. Immunotherapy 2024; 16(14-15): 949 doi: 10.1080/1750743X.2024.2382670
|
| 7 |
Antineoplastics/methyprednisolone. Reactions Weekly 2022; 1929(1): 92 doi: 10.1007/s40278-022-25716-5
|